Parameter | No. of patients | MBD1 (low) | MBD1 (high) | Spearman correlation | P value |
---|---|---|---|---|---|
Sex | 0.107 | 0.333 | |||
Male | 45 | 16 (35.6%) | 29 (64.4%) | ||
Female | 39 | 10 (25.6%) | 29 (74.4%) | ||
Age (years) | − 0.020 | 0.859 | |||
< 60 | 40 | 12 (30.0%) | 28 (70.0%) | ||
≥ 60 | 44 | 14 (31.9%) | 30 (68.1%) | ||
Tumor size (cm) | 0.085 | 0.441 | |||
≤ 5 | 53 | 18 (33.9%) | 35 (66.1%) | ||
> 5 | 31 | 8 (25.8%) | 23 (74.2%) | ||
Differentiation grade | 0.182 | 0.098 | |||
Well-moderate | 31 | 13 (41.9%) | 18 (58.1%) | ||
Poor-undifferentiated | 53 | 13 (24.5%) | 40 (75.5%) | ||
T stage | 0.036 | 0.742 | |||
T1–T3 | 56 | 18 (32.1%) | 38 (67.9%) | ||
T4 | 28 | 8 (28.6%) | 20 (71.4%) | ||
Lymph node status | 0.378 | < 0.001 | |||
Negative | 55 | 24 (43.6%) | 31 (56.4%) | ||
Positive | 29 | 2 (6.9%) | 27 (93.1%) | ||
Distant metastasis status | 0.299 | 0.006 | |||
M0 | 53 | 22 (41.5%) | 31 (58.5%) | ||
M1 | 31 | 4 (12.9%) | 27 (87.1%) | ||
TNM stage | 0.287 | 0.008 | |||
I–II | 34 | 16 (47.1%) | 18 (52.9%) | ||
III–IV | 50 | 10 (20.0%) | 40 (80.0%) |